A prospective study of measurement of circulating tumor DNA during neoadjuvant chemotherapy for esophageal cancer
Not Applicable
Recruiting
- Conditions
- resectable advanced esophageal cancer
- Registration Number
- JPRN-UMIN000029788
- Lead Sponsor
- Wakayama medical university
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 40
Inclusion Criteria
Not provided
Exclusion Criteria
The patients follow our protocol.
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The correlation of the amount of circulating tumor DNA before and after neoadjuvant chemotherapy and the relapse-free survival
- Secondary Outcome Measures
Name Time Method